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Vaccines in aquaculture are heading into the 21st century facing old challenges with new 
possibilities. Fish die each year as a result of inefficient vaccination against intracellular 
pathogens e.g. infectious pancreatic necrosis virus (IPNV). A successful prophylactic strategy 
to combat viral diseases like IPN in fish farming depend both on innate immune responses, 
like cytokines and natural killer cells, and on specific responses, like antibodies and cytotoxic 
T cells. In new vaccine strategies for fish, knowledge of how to effective stimulate innate 
immune responses is essential.  
In this study we have investigated the expression of pro-inflammatory cytokines after 
injection of empty fluorescent Poly(D-L-lactide-co-glycolic) acid particles (PLGA) to see 
what affect PLGA particles have on the immune response per se. 
Four groups of Atlantic salmon of ~80 g were intraperitoneally injected with respectively 
NaCl (0.9%), LPS (1mg/kg), PLGA (108 particles/fish) and a mixture of PLGA (108 
particles/fish)/LPS (1mg/kg). Tissue and cell samples were collected at day 2, 4, 7, 14 and 30 
post-injection. Cell samples were taken from head kidney and peritoneum, and tissue samples 
from liver and spleen.  
The expression of the pro-inflammatory cytokines, IL-1b, IL-6, IL-8 and TNF-α1 in 
peritoneum, spleen, liver and head kidney macrophages was measured using Real time 
Reverse transcriptase Polymerase chain reaction (Real-time RT-PCR).  
In head kidney macrophages and peritoneum the expression levels in the 3 experimental 
groups, injected with PLGA, LPS and a PLGA/LPS mix were low throughout the whole 
sampling period. Expression of IL-6 in liver was too low to be detected in all 3 experimental 
groups and also in the saline injected fish. The results from spleen and liver of fish injected 
with PLGA/LPS and LPS showed elevated levels of especially TNF-α1, IL-6 and IL-8 at 
early stages (2-4 days), and overall elevated mRNA transcript levels were detected at early 
stages. 
The particles were labelled with 6-coumarin, for a visual study of intraperitoneal (ip)-cell 
samples. Fluorescent PLGA particles were microscopic visualized in connection to ip-cells up 
to 14 days post-injection. An attempt to evaluate distribution patterns of PLGA particles in 



















1.1. Innate immunity in fish 
Immunology is “the study of the bodies´ physiological defense against what the body 
considers as non-self or alien/foreign” [1]. One refers to this physiological defense as the 
immune system, because of the many different cells that interact to give responses to invading 
micro-organisms. Leukocytes are the main cells of the immune system and are localized to 
certain organs and tissues [1]. Bone fish have lymphoid organs as head kidney, thymus, 
spleen and some lymphoid tissue, but do not possess lymph nodes and bone marrow as 
mammals do [43, 75]. The head kidney is considered to be the most important lymphoid 
organ as it is haematopoietic [22, 43]. Circulation in between the lymphoid organs occurs in 
the blood and lymph-veins.  
The immune system of higher vertebrates can be divided in two sections; the innate (IIS) and 
the adaptive (AIS) immune system [1, 20, 67]. These to sections often cross each other in 
functions and work together to give an effective immune response and innate immunity is 
crtitical for activating adaptive immunity. From a phylogenetical point of view, fish are one of 
the first classes of vertebrates that evolved to possess an adaptive part of the immune system 
[74], with teleosts being the most developed class of fish [67, 75].  
The IIS in fish consist of physical barriers like mucus, scales, mucosal surfaces (epidermis, 
gills, intestine) that provide an obstruction to invaders. In addition the mucus of fish may 
contain immune factors like lectins, pentraxins, lysozyme, complement proteins, antibacterial 
peptides and  immunoglobulin M (IgM) [53]. Secondly, the IIS provides different cells to 
handle invaders (Table 1). Monocytes/macrophages and granulocytes (neutrophils) are the 
key cells of the innate defence system in fish [2, 23, 64], and as shown in mammals, are 
recruited to the site of infection by messenger proteins (e.g. chemokines). Macrophages and 
granulocytes are also located in other tissues than the kidney. The resting population of 
leucocytes in the peritoneum i.e. of fish has been shown to consist of macrophages (40%), 
leukocyte-like cells (55%) and neutrophils (2%) [23]. In response to an intraperitoneal (ip) 
injection of bacteria, a high influx of neutrophils and are seen after 24-48 h the neutrophils 
has been shown outnumber the macrophages in the peritoneal cavity [2]. Neutrophils are 
short-lived phagocytising and active secreting cells, while macrophages are the more long-









of leucocytes, and antigens are considered to be taken up by the endothelial reticular cells in 
the ellipsoids of the tissue [80]. 
After entering the extravascular site the monocytes may differentiate into macrophages [1]. 
Monocytes and macrophages are two stages of the same cell lineage of phagocytic cells, 
called mononuclear phagocyte system (MPS) [1]. Macrophages will recognize general 
pathogen characteristics normally not found on the cell surface of any eukaryotic organisms, 
that are highly conserved in a wide range of micro-organisms, e.g. bacterial and fungal 
moieties such as lipopolysaccharides (LPS) and ß-glucan [53]. Collectively these patterns are 
called Pathogen Associated Molecular Patterns (PAMPs) and macrophages “see” them by 
surface receptors [1, 3, 42], also known as pattern recognizing receptors (PRRs). 
Macrophages can be activated both through this recognition of PAMPs and also by interferon-
γ and cytokines produced by themselves or other cells [1, 54]. Besides antigen presentation, 
the action of macrophages are to modulate other cells action by secreting products like 
enzymes, antimicrobial peptides, oxygen- and arachidonic acid metabolites and 
 
 
Table 1: Examples of components of the innate immune system of teleosts [53]. APP: acute phase protein. 
TLR=Toll like receptor (a main receptor among PRRs, others are, i.e.mannosereceptors) 
 
Innate immune components 
in teleosts Mode of action 
Physical components  
Fish scales Physical obstacle 
Mucous surfaces 
Viscous glycoproteins gives a physical obstacle, and contains antiseptic 
enzymes 
Non-cellular (humoral)  
Transferrins 
Iron-binding APP, making an iron-free environment, depleting the iron-
source from pathogens. Growth inhibitor. 
Lectins Carbohydrate-binding, recognizes carbohydrate moieties on bacteria 
C-reactive protein (lectin) 
APP, levels increases in inflammatory responses, binds to phosphorylcholins 
on microbes and assists in complement binding 
Lytic enzymes 
These enzymes are innate opsonins, changing the surface charge of microbes 
and facilitating phagocytosis 
Anti-bacterial peptides, 
proteins Effect on bacteria, either bacteriostatic or bacteriolytic 
Interferons/MX-proteins Inhibiting viral replication  
Enzyme inhibitors Blocking and inactivating/decreases enzyme activity 
Mucus See above, and page 1 
Complement Biochemical cascade that may lead to removal of pathogens 
Cellular  
Natural killer cells (NK) “Kill cells” missing MHC class I molecules on cell surface 
Phagocytic cells with TLR 
and "burst" activity PRR harbouring and exhibit many different responses 











cytokines, and to actively phagocytose microbes [1, 80]. 
An important family of receptors which are found to recognize different entities in the first 
encounter of microbes, are the Toll-like receptors (TLR) [3, 42]. The TLR family has 
receptors for nucleic acid, proteins, lipids and polysaccharides. The recognition often initiates 
endocytosis of the alien agents and results in intracellular signalling with production of 
several cytokines.  
There are found 10 different TLR in mammals, in fish there has been identified more [37]. 
Some TLRs work with different ligand specificities and expression patterns and knowledge of 
how different TLR`s function are important. In mammals the TLR 4 is the main receptor for 
LPS [34]. LPS is an important constituent in the outer layer of Gram-negative bacteria, and it 
consists of 3 parts; an O-specific polysaccharide, a core polyoligosaccharide and a lipid A. 
The lipid A-layer is responsible for activation of innate immune responses in mammals, also 
referred to as the endotoxin in LPS [52]. In mammals, the binding of LPS to TLR is acchieved 
through a complex of factors (Fig. 1), and this triggers an intracellular cascade dependent on 
MyD88, which leads to removal of the inhibitor of NF-kB and release of p50 and p65 
subunits which again enters the nucleus and drive the expression of pro-inflammatory genes 
[28]. LPS binding also leads to antiviral gene expression through an alternative pathway 
independent of MyD88 [37]. Comparative studies have shown that fish and lower vertebrates 
are resistant to the toxic effect of LPS that in mammals can cause a septic shock [7].  
In vitro studies in fish show that there is a need for extremely high LPS concentration to 
induce immune responses in comparison to mammals [51], and this could be due to 
differences in their recognition of LPS [36]. Some studies suggests that fish lack some 
components in the TLR 4 pathway or use a different receptor pathway, and this leads to an 
attenuated LPS sensitivity [37].  In addition there is no trigging of antiviral genes after LPS 
challenge in fish, which can suggest another signalling pathway being used [37]. There are 
also questions on how well TLR4 genes are conserved in across lower vertebrates, and 
although zebrafish, Danio rerio, do show homologues, this is not shown in e.g. pufferfish, 
Fugu and Tetradon, [37].  
Lastly, there is the humoral (non-cellular) response in fish (Table 1), and according to 
Magnadottir (2006), this part is classified according to the components impact on PRR or 









In mammals, the innate immunity is fundamentally important for an effective adaptive 
immune response to occur [24], and this is also the case in fish [20]. It could also be that 
teleost need to rely more on the innate immunity when opposing pathogens [5, 6, 23, 38] since 
the humoral immunity of fish is deficient of e.g. IgG and IgE. In fish and other ectothermic 
vertebrates the adaptive part of the immune system is temperature dependent, and thereby 
limiting, since a high antibody response may be necessary for a protective outcome [48]. 
Temperature and time to develop specific immunity are inversely related, the lower 
temperatures of the fish the longer time it will take for the adaptive immunity to develop [5, 
23]. Antibody production after vaccination under even optimal temperatures for salmon (12-
14OC) is known to start after 4-6 weeks compared to fish living in warm-waters of 22OC, 
where antibodies are detected after one week post-immunization [23]. It is a disputed issue 
whether the innate response in fish is delayed due to a lowered temperature. Some findings 
support that the innate immunity in fish is affected by temperature, and that fish react fast to 





Figure 1: Toll-like receptor 4 – complex and the MyD88 dependent pathway. LPS` in the blood binds 
either directly or by LPS-binding proteins (LBP) in the blood to a CD 14 (membrane-linked protein) and 
TLR4. Together with MD2 a signal cascade through Myeloid differentiation factor 2 (MyD88) is initiated 
and eventually leads to transcription of pro-inflammatory cytokines like TNF-α, IL-1,IL-8 and IL-6 











1.1.1. The acute phase response 
In response to tissue damage, stress or microbiological intruders an inflammatory response is 
initiated. This first response is referred to as the acute phase response (APR) [6, 26]. The APR 
response is recognized by an increase in plasma concentration of different acute-phase 
proteins. The different APP products have various functions, such as transferrins and 
metallothenins that are responsible for depleting the pathogens of nourishment sources, while 
some are taking part in maintaining homeostasis and regulations, and others are transport 
proteins [5, 77] The acute phase normally starts within hours and subsides within 24-48 h 
[11]. After this the organism will return to normal. The acute phase response may persist and 
turn into to a chronic inflammation. In fish this acute phase response may be delayed due to 
environmental temperature as mentioned and it can take more than two days for it to subside 
[88]. 
The cardinal signs of inflammation are redness (rubor), heat (calor), swelling (tumor), pain 
(dolor) and the tissues involved show a lack in functionality (function laesa). Inflammation 
can be divided in two sections [1];  
1. The exudative components that have an effect on fluid flow. Blood veins upstream of 
the inflammatory localisation will increase, sending more blood which will cause heat 
and redness. The blood veins down-stream will decrease to minimize drainage. At the 
same time there will be an increase in arterial wall permeability that allows more 
blood plasma to flow to the site of infection.  
2. The cellular part includes leukocytes that migrate to the site of inflammation, and 
deals with present threats. In response to production of i.e. the pro-inflammatory 
cytokines IL-1β and TNFα1, the endothelial cells at the site of infection express on 
their surface enhanced levels of adhesion molecules, selectins and integrins. Each of 
these molecules enhances specific migration of leucocytes to tissue [1, 85].  
 
 
1.2.1. Pro-inflammatory cytokines 
Cytokines are a group of messenger polypeptides, produced by a variety of cells. Cytokines 
are important for the immune-cells to co-work, and are considered to have an impact on 
modulating and directing the immune cells in different ways and for being the chief 









Most cytokines have multiple sources, multiple targets and multiple functions (pleiotrophy) 
[26]. Cytokines are usually products from a TLR mediated signalling and the classical 
transcription pathway leading to activation of nuclear factor kappa B (NF-kB) [13, 33] This 
pathway plays a central role in cardiovascular growth, stress response, and inflammation by 
controlling gene network expression. Cytokines work primarily in a paracrine (short range) 
and autocrine (on itself) manner through receptors, but they are also shown to work in an 
endocrine like way [1, 41, 85].  
Cytokines responsible for inflammatory responses are often divided in 2 groups [25], those 
involved in acute inflammation, and those involved in a more chronic inflammation. TNF-α, 
IL-1β and IL-6 are cytokines most relevant in initializing the APR, but they also play a role in 
a more chronic inflammation and also in activating the AIS [6, 20]. Primarily pro-
inflammatory cytokines are produced by monocytes and macrophages and targets are often 
different in an inflammatory response [85].  
Following inflammation, the cytokine cascade begins with production of TNF-α from 
macrophages, NK cells or mast cells. TNF-α is usually the first signal of inflammation in fish 
as it is in mammals [79]. TNF-α have been characterized so far in rainbow trou, 
Oncorhynchus Mykiss, and Japanese flounder, Paralychtys olivaceus [32, 45].  In fish this 
cytokine is known to give a mitogen-like response of head kidney cells and induce activation 
of fish macrophages with macrophage activation factor (MAF) as a resulting product. TNF-α 
can be detected in gills, kidney and blood leucocytes of unstimulated fish [45]. Its effect as a 
pro-inflammatory conductor often overlaps and synergize with the effects of IL-1β, which is 
one of the key mediators of the body’s response to a microbial invasion. IL-1β has been 
characterized in a large number of bony fish, including rainbow trout [15, 78]. IL-1β may 
induce a general increase in a wide variety of other factors associated with inflammation and 
in particular other cytokines [10]. Expression of IL-1ß has shown to be negatively influenced 










Figure 2: Production of IL-1, IL-6, IL-8 and TNF in the inflammatory response. Triggering signals as 
stress, cuts, pathogens cause macrophages to produce IL-1 and TNF, and cause a variety of actions due to 
this cytokine expression. IL-6 is the main conductor for acute phase protein expression and work on the 
hepatic “side” for this production, whereas and IL-1 TNF also affects the acute phase response. IL-8 as a 
chemokine will work to attract more neutrophils to the site of infection [85]. 
 
Together IL-1β and TNF-α1 induce migration of neutrophils and macrophages by inducing 
itself, other resident macrophages and neutrophils to produce chemokines like IL-8 at the site 
of infection [85].  
IL-8 is a chemokine or chemoattracting protein. It is the main attributor to activate neutrophils 
and make sure that they migrate to the site of infection, and also for the activation of 
degranulation [71]. IL-8 is produced mainly by macrophages and the production is stimulated 
by cytokines, as mentioned above,(IL-1β and TNF-α1), bacterial products as LPS, viral 
products (dsRNA) and certain plant products [85]. IL-8 is a very stabile chemokine. It can 
endure heating up to 100OC, and pH between 2.4 and 9.0 without any significant decrease in 
its bioactivity [85]. The gene for IL-8 has been sequenced fish, i.e. in Japanese flounder, 
rainbow trout and channel catfish, Ictalurus punctatus [15].   
IL-6 is also one of the first cytokines to be produced, and is known to be the main stimulator 
for the production of acute phase proteins during acute phase response in human, and as an 
attributor to the migration of neutrophils to the infection site [1, 26, 85]. In addition IL-6 may 
play a part in Ig-production, and monocyte and lymphocyte differentiation [35, 62]. The 









T-lymphocytes, neurons and fibroblasts [1, 35]. The gene for IL-6 was first characterized in 
Japanese pufferfish, F. rubripes, in 2005 [9], and its function in fish compared to mammals is 
not clear yet. 
1.2. Vaccines in intensive fish farming 
Vaccines consist of non-toxic antigens that are injected, ingested or inhaled to induce a 
specific defence response, without actually going through the disease process. Either by using 
components of the pathogen (antigens), attenuated or inactivated forms, one wish to stimulate 
the protective adaptive immune responses [1, 8].  
During the last decades, there has been a continuous growth in the aquaculture industry all 
over the world [60, 82]. Any intensive bioproduction, whether on land or at sea, will likely 
suffer from disease problems [27]. Prophylactic treatments and good management practises 
can usually prevent or reduce the susceptibility to diseases, but not entirely. During the 1980`s 
the salmon industry experienced great losses due to bacterial diseases, mostly caused by 
Vibrio sp, and the use of antibiotics increased dramatically [49]. The introduction of well-
working vaccines in aquaculture has been the main reason for the decrease in antibiotic use 
[27]. 
It is shown that attenuated pathogens in most circumstances lack the ability to give a cellular 
adaptive response that is important to eradicate e.g. virus and other intracellular pathogens, 
and there is an obvious need for development of such protection [8, 81, 86]. Oil-adjuvanted 
vaccines, which is the most commonly used vaccine formulation in Norwegian aquaculture 
[27], have shown sub-optimal efficacy against virus infections (e.g. infectious pancreas 
necrosis virus (IPNV)) and against some intracellular bacteria like Piscirickettsia salmonis. 
The challenge for vaccine developers, in general, has been to produce vaccines that activate 
this cellular (Th1) arm of the immune system, that handles intracellular pathogens [27, 63, 
81]. In addition, vaccines that increase cytotoxic CD8+ T cell (Tc) responses are also highly 
wanted. Activation, proliferation and differentiation of naïve T-cells is dependent on 
presentation of peptide fragments and second signals (cytokines) from APC. APCs are 
phagocytic cells with the ability to engulf and process these peptide fragments of the antigen, 
and activating the naive T-cells by externalizing the peptide fragments on a major-









1.2.1. Poly (D-L-lactide-co- glycolic) acid (PLGA) as a vaccine carrier. 
When new vaccine formulations are taken into consideration, there are many aspects to 
consider; effectiveness in getting the correct immune response is one, while economic aspects 
and toxicity are others. A highly promising technology is based on polymeric nanoparticles. A 
particle delivery system consists of a carrier that permits a sustained or pulsed release of 
encapsulated antigens and adjuvants [50]. Nanoparticles is such a delivery vehicle (To be 
defined as nano-technology, the size of particles must be <100 nm) with a therapeutic agent of 
interest encapsulated or adsorbed/conjugated to their surface are of high interest now-a-days. 
This new nanotechnology devices gives an opportunity to deliver small molecular weight 
drugs, as well as macromolecules such as proteins, peptides or genes to tissue of interest [58]. 
By adsorbing different ligands and antigens to the nanoparticle and knowledge of how the 
adaptive immune response works together with the innate, one can adjust the concept to a 
desired immune response. PLGA are prepared from lactide and glycolide, which are cyclic 
esters of lactic acid and glycolic acids [31]. PLGA is synthesized by means of random ring 
opening co-polymerization of two different monomers, the cyclic dimer (1, 4-dioxane-2,5-
diones) of glycolic acid and lactic acid (Fig.3).  
In general, the polyester can be made highly crystalline (e.g. poly(L-lactic acid)), or 
completely amorphous (e.g. poly(D,L-lactic-co-glycolic) acid), and made in almost any 
micro- and nanosizes, with a capability of encapsulating almost any molecule [39].   
PLGA is biodegradable and biocompatible [31], and is approved by the US food and drug 
administration (FDA) [44], and has shown little or no systemic toxicity [14]. PLGA has been 
used for ages in medical and pharmaceutical fields, as sutures, bone fixatives, artificial skins 
and cartilages, dental materials, materials for bone regeneration, drug delivery and others. 
Today PLGA particles is used in at least 12 different marketed products, and are capable of 
releasing peptides and proteins slowly and continuously from 1 to 4 months [39]. 
PLGA particles have been shown to be taken up in vivo by the main APCs in mammals, 
dendrittic cells [65, 89]. and using PLGA nanoparticles as antigen delivery vehicles have 













Figure 3: Left: The synthesis of PLGA. PLGA is synthesized from two monomers; glycolic acid (top left) 
and lactic acid (top right) [31]. Right: Water-in-oil-in-water (W/O/W) emulsification solvent evaporation 
method is the most used method for making PLGA nano particles. First a water phase (PVA) and antigen 
is homogenised/sonicated in a polymer solution (PLGA + chloroform), before a second emulsification is 
included in a second water phase (PVA) and the solution is left stirring for the organic solvent to 
evaporate. 
 
cytotoxic T-cell activity.  
The way of uptake of PLGA nanoparticles has been investigated in mammalian smooth 
vascular cells and endothelial cells, and the result indicated that the particles are internalized  
efficiently through an endocytic process and the uptake is concentration- and time-dependent 
[17, 68]. The process seems to be saturable. The exact way of endocytosis is not determined 
and it would depend on particle size, ligands adsorbed, and the level of antigen exposed on 
the surfaces. Adjusting such features may result in an altered organ- and tissue distribution. 
Studies in mammalian DC also show increased maturation after stimulation of PLGA 
microparticles alone [89]. 
A nanosize also gives another merit, it has been shown that 100 nm particles are taken up 
more easily compared to larger sized particles [19], and can penetrate sub mucosal layers, 
where larger particles can not [18].  
By using PLGA particles or other polymers there is a potential for reducing both the number 
of administration and the amount of vaccine antigens required to induce protection. A 
problem in aquaculture in addition to the problems with a sub-optimal Th1 response 
activation, is side-effects (peritoneal melanization process, internal adhesions and 









carriers such as PLGA particles may be a mean to decrease such side-effects (not caused by 
fault-injections). 
PLGA particles as a vaccine carrier in fish have only been investigated once [47], then in an 
oral vaccination try-out for rainbow trout. The antigens were in this study attached more to 
the surface area of the PLGA particles than incapsulated. Further investigations will show 
whether these particles can encapsulate and release antigens in an efficient fashion, without 
the chronic peritonitis as seen when using oil-adjuvant vaccines 
In this study we have chosen to use LPS as a positive control, since it is a known stimulant in 
fish.  
 
1.3. Objectives  
To develop vaccines with higher Th1 stimulating ability we chose to use PLGA carriers as they 
have been shown to increase vaccine efficacy against intracellular pathogens in mammalian 
studies [56, 59]. Before analysing their Th1 stimulating activities, we were interested in 
whether the PLGA could induce immune responses per se. Subsequently, expression of acute 
phase cytokines either alone or in conjunction with a known stimulant, namely bacterial 
lipopolysaccharides (LPS) was analyzed. In addition, a prerequisite for a high vaccine efficacy 
is a high-level MHC presentation of peptides by APC that occurs after uptake and degradation 
of e.g. a pathogen or antigen loaded particles. Hence uptake studies would suggest whether the 
particles were phagocytised or not. This would create a basic knowledge platform for further 
exploitation of this concept. 
 
Thus, the aims of this study were to:  
1. Investigate the level of IL-1β, IL-6, IL-8 and TNF-α1 transcripts at early time-points 
post-injection of PLGA alone or together with LPS.  
2. Locate fluorescence labelled PLGA in tissues after intravenous (i.v.) injection. 
3. Microscopically study the uptake/association of PLGA in/to peritoneal phagocytic cells 









































A total number of 50 Atlantic salmon (Salmo salar) with an average weight of 80 g was used. 
The fish were supplied by Aqua Gen Norway AS, Hemne AS and kept at Havbruksstasjonen I 
Tromsø AS, Kårvika. The light regime was 12 h light/day, and the freshwater temperature 
was kept at 40C.  The fish were healthy, had not been vaccinated and were fed with 3 mm 
Skretting Nutra parr LB (Skretting AS, Norway) (appendix 1). Procedures involving animals 
and their care were conducted in conformity with institutional guidelines complying with 
national and international law and regulations.  
 
2.1.2. Lipopolysaccharide (LPS)  
LPS was extracted from Aeromonas salmonicida ssp salmonicida by use of the phenol-water 
extraction method [87] at the institute of marine biotechnology at the Norwegian College of 
fishery science, UiTØ. Protein contamination was measured to be 0.25 %. 
 
See appendix 2 and 3 for chemicals and solution tables 
 
2.2. Methods 
2.2.1. Making of PLGA particles  
The making of PLGA particles was done according to Davda and Labhasetwar (2002) with 
modifications. A 2% PVA solution was prepared in cold dH2O, saturated with 25 uL 
chloroform and centrifuged at 1000 rpm (Labofuge 400R) for 5 min and then filtered through 
a 0.22 µm filter to remove any undissolved PVA.  
PLGA particles with 6-coumarin were prepared using the water-in-oil-in-water (W/O/W) 
emulsification solvent evaporation method according to Davda and Labhasetwar (2002) with 
some modifications. This method has been used extensively for encapsulation of antigens. 
Here we made empty particles labelled with 6-coumarin, a fluorescent labelling, to ensure 
tracing of the particles. Primary solution water-in-oil (W/O) was prepared; 300 mg PLGA was 
dissolved in 6 ml chloroform. 100 µl of a stock solution (0.5 mg/ml (6-coumarin/chloroform)) 
was added to 6 ml chloroform in advance, equivalent to 15.8µg/ml.  








Nine hundred µl of 10% PVA was added in two portions to the PLGA solution by vortexing 
for 1 min after each addition. The suspension was then cooled on ice for 5 min. 
Emulsification to obtain a primary water-in-oil emulsion was performed by sonication at 35% 
(Sonics Vibra cell) for 2 min1.5 ml of aqueous solution containing 10% w/v PVA was added 
dropwise to the organic phase, while homogenizing for 2 minutes at 24000 rpm (Ultra-
Turrax).The primary W/O phase was added in two portions to 40 ml 2% PVA solution with 
intermittent vortexing to obtain the multiple W/O/W emulsion. The emulsion was placed on 
an ice bath for 5 min and then sonicated at 30% for 4 min (Sonics Vibra cell). 
The W/O/W emulsion was left stirring overnight on a magnetic stir plate to allow evaporation 
of the chloroform and formation of the particles. The suspension was then transferred to a 
centrifuge tube and centrifuged at 9000 rpm (9800 x g) for 10 min at 40C with a j.26 XP 
centrifuge.The particles were resuspended in distilled water and sonicated for 5 sec at 20% on 
an ice-bath to disperse any aggregates. Washing and centrifugation was repeated twice. These 
washing-steps should remove PVA-residues. 
The PLGA particles were resuspended in 7 ml of trehalose after the last centrifugation and 
sonicated at 20% for 10 sec. Then they were transferred to a Nunc-centrifuge tube and 
centrifuged at 500 rpm (48 x g) for 3 min at 4OC to remove any large aggregates. The 
supernatant was collected and frozen at -70OC for 45 min and subsequently lyophilized for 2 
days (Hetolab FD3). The PLGA particles were stored at 4OC. 
  
2.2.2. Characterization of PLGA particles 
2.2.2.1. Size measurement 
Distribution of size was conducted in aqueous dispersion using a dynamic laser defractometer 
(Nicomp). First the machine was calibrated using a DURAN bottle containing particle-free 
milli-Q water. The milli-Q water was filtrated through a mesh to ensure no unwanted particles 
are faulty taken into the calculations. All equipment used was also washed in particle-free 
milli-Q water. The PLGAs were diluted in a DURAN bottle and counted. 
 
2.2.2.2. Surface characterization 
A JSM-6300 scanning electron microscopy was used to determine the surface topography of 
the PLGAs. This work was carried out by Børge Fredriksen, PhD student, IMAB. 
 








2.2.2.3. Fluorescent labelling 
The PLGAs were resolved in 5% trehalose therafter transferred to an object glass for visual 
study to detect the fluorescence. 
Fluorescence labelling and morphology were inspected using Leica DM600B UV-microscope 
and Leica application suite software (Leica Microsystems GmbH Wetzlar, Germany) against 
a control of non-labelled PLGA particles. The particles were inspected with the magnifier set 
to 40X/0, 75.  
 
2.2.3. Distribution of PLGA particles in tissue after i.v. injection. 
2.2.3.1. I.v. injection of PLGA particles into fish (pilot) 
Five fish were i.v. injected in the caudal vein with 100 µl of 1x108 PLGA particles/fish. Four 
fish were injected each time and 1 fish was kept as a control without any injections. Samples 
were taken after 3 h from liver, spleen, head kidney, gills and heart. This i.v. injection was 
repeated. 
2.2.3.2. Sampling for histology. 
Samples of head-kidney, liver, peritoneum, and spleen for histology were transferred to 20 ml 
plastic vials containing 10% formalin and kept there for 48 h. Thereafter the samples were cut 
into smaller pieces and put in Tamro processing embedding cassettes w/lid and soaked in 70% 
EtOH. Two different histology processing methods were used; 1: using xylene, and 2: a non-
xylene method using isopropanol.  
1. The samples were dehydrated by the help of a Shandon citadel 1000 machine. The citadel 
1000 consisted of 12 wells with the following content: 
1: Empty 
2: Empty 
3: 96% EtOH (2h)* 
4: 96% EtOH (2h) 
5: 100% EtOH (2h) 
6: 100% EtOH (2h) 
7: 100% EtOH:Xylene (1:1) (1h) 
8: Xylene (1h) 








9: Xylene (1h) 
10:Xylene (1h) 
11: Xylene: paraffin wax (1:1) (1h) 
12: Paraffin wax (3h minimum) 
*The period of time the samples were left in each well. 
 
The cassettes were collected the next day. It is important that the samples are collected before 
the machine terminates, before the paraffin-oil congeals. Following this the tissue samples 
were covered with paraffin using a Leica EG 115 OH and left to cool down on an Axel 
Johnson CP-4 cooling plate. 
The samples were cut into 5 µm sections with a Leica RM2235 and the section was 
transferred into a water-bath, 400C. The sections were collected and put on to object-glasses, 
dried and put in a heating cupboard at 600C for 30 min to loose the paraffin. The object 
glasses were then transferred into a xylene-bath for 5 minutes. A cover glass was mounted in 
a drop of histokit. 
The visual analysis was done using a Leica UV-microscope. The amplifier was set to  
40x/0.75 and pH 2. 
2. Processing histological cuts using isopropanol. 
The samples were dehydrated manually: 
1. Formalin (30 min) 
2. Formalin (30 min) 
3. Water (30 min) 
4. Isopropanol (1 h 30 min) 
5. Isopropanol (2 h) 
6. Isopropanol (2h) 
7. Paraffin (1h) 
8. Paraffin (1h) 
9. Paraffin (1h 30 min) 
10. Paraffin (2h)              
After the dehydration-protocol, the same procedure as the previous section (histological cuts 
using xylene 2.2.3.2.) was followed. 
 








2.2.4. Gene expression profiling after ip injection  
2.2.4.1. Injection  
The experiment was divided in 4 groups, in each case the fish were injected ip with 200 µl of 
respectively; 
1: 0.9 % NaCl 
2: PLGA nano particles (376 nm) 108 particles/fish 
3: LPS extracted from A. salmonicida ssp salmonicidae (1mg/kg) 
4: PLGA nano particles (108 particles/fish) and LPS (1 mg/kg) 
The fish were sedated using benzokain (1 mg/l from a 5% stock solution) before the injection.  
 
2.2.4.2. Sampling 
Samples from the fish were collected after 2, 4, 7, 14 and 30 days. Two fish pr group at each 
time-point were sacrificed. The individual samples from each group were pooled before RNA 
isolation. Cell samples were obtained from the peritoneum and head kidney. Tissue samples 
from liver, peritoneum and spleen were collected, put on RNAlater and kept at -200C 
.  
Collection of intra peritoneal (ip) cells 
The method for collection of ip cells has been developed by Kolaczkowska (2001). At the 
selected time-points the peritoneal cavity was injected with 5 ml L-15 transportmedium (TM). 
The peritoneal region was massaged before it was cut open and the liquid was collected using 
a bunt 1 ml pipette-tip and transferred to a 10 ml centrifuge tube and transported back to the 
lab on ice. The bunt tip would prevent penetrating the organs of the peritoneal cavity.  
The liquid was centrifuged for 10 minutes at 300 x g and the cell pellet was collected and 
resuspended in 1 ml L-15 w/0.1% FCS. This suspension was further transferred to a Nunc 24-
well tray. For visual studies 100 µl of each well was transferred to wells covered with a sterile 
circular cover glass and 900µl L-15 w/0.1% FCS.  
All wells were incubated for 1 hour at 12OC. 
The cells for visual analysis were afterwards washed with 1xPBS 3 times, and then fixation 
was concluded with the addition of 200 µl 10% formalin. The last incubation lasted for ½ 
hour at 12OC. Again the cells were washed with PBS and the cells were collected and 
mounted on an object-glass using Aquamont, before further visual examination. The visual 
analysis was done by Leica DM600B UV-microscope and Leica application suite software. 








The amplifier was set to 40x/0.75 pH 2. 
The ip-cells for expression analysis were not washed but immediately after incubation added 
500 µl TRIzol reagent. The suspension was transferred to new eppendorf tubes and kept at -
800C until further RNA isolation. 
 
Collection of head kidney macrophages 
The fish was killed by a blow to the head and blood was depleted by using vacutainers, before 
opening the peritoneal cavity and removing a part of the head kidney with sterile dissection 
equipment. 
The head kidney was cut out and transferred into a 50 ml Nunc tube containing transport 
medium. 
In a sterile cabinet the head kidney was cut into 3-4 pieces and crushed before it was strained 
through a 100 µm cell strainer using 1-3 ml of TM. Further the solution was transferred to a 
37 %/51 % Percoll-gradient. This gradient will separate the head kidney macrophages from 
the rest of the head kidney cells. 
The gradient was centrifuged at 400 x g for 40 minutes at 4oC using a Multifuge 1 S-R 
centrifuge. The cell-layer between the two layers was collected with a sterile Pasteur-pipette 
and washed twice with 10 ml L-15 medium. The washing procedure was done by 10 minutes 
centrifugation at 300 x g. The pellet was resuspended in L-15 incubation medium (IM). 
The cell number was estimated to 1x 106 cells/ml using a Bürker chamber (Assistant) and a 
Nikon TmS magnifier. The cells were later transferred to a 24-well tray (Nunc) with a total of 
1x106 cells/well. After incubation for 2 h, the cells from each group (2 fish pr group) were 
pooled together and added 500 µl TRIzol and frozen at -80OC. 
 
 
Isolation of total RNA  
RNA isolation was performed according to Chomczsynski (1987), with modifications. The 
tissue was cut into a small piece (~30 mg), one from each individual in the group at each 
sampling (pooling), and transferred to a 11 ml Greiner tube containing 1 ml TRIzol. This was 
homogenized using an Ultra-turrax T-25 Basic and the suspension transferred to eppendorf 
tubes. The homogeniser was washed with chloroform→ 70% EtOH→ milliQ-water →DEPC 
water between each sample.  








The samples were further centrifuged at 12000 x g for 10 min at 4OC.  
After this, both cell samples and tissue samples followed the same procedure. Two hundred µl 
chloroform were added pr ml TRIzol, vortexed for 15 sec at RT and incubated in RT for 5 
min. The samples were then again centrifuged at 12000 x g for 15 min and 4OC. The RNA 
containing water-phase was transferred to a new Eppendorf tube and added half the 
chloroform and TRIzol amount used in the preceding section. And the procedure was 
repeated.  
The water-phase was transferred to a new Eppendorf tube and added 500 µl isopropanol to 
bleed off the RNA. The samples were vortexed briefly and incubated in RT for 10 minut, 
before centrifugation at 12000 x g for 10 min at 4OC. The isopropanol was removed. The 
pellet was then washed with 1 ml 70% EtOH/DEPC and centrifuged at 7500 x g for 5 min. 
Again the liquid was removed and the pellet was left to dry on the bench. It is important not to 
let the RNA dry to long, but just long enough for the EtOH to evaporate. The pellet was then 
dissolved in 30 µl nuclease-free water and heated for 10 minute at 55-60OC. The RNA was 
then frozen immediately at -80OC. 
Quality of the RNA was checked by gel-electrophoresis. For each sample the following 
mixture was prepared; 2 µl of RNA (sample), 4 µl nuclease-free water and 3 µl of 
formaldehyde loading buffer. The 1% agarose gel containing EtBr was prepared in advance. 
The sample mixture was loaded on to the gel, and the power supplier (Powerpack 300) was 
set to 250 V and 12 min. 28S r RNA and 18S rRNA would appear as two bands. Visualization 
was done using a GeneGenius Bio imaging system. 
The amount of RNA and further quality-check was done using a nano-drop. 1.5 µl of the 
sample was loaded on to the spectrophotometer and measured. A260/280 should be in the range 
of 1.8-2.1.  
All RNA samples were DNase-treated after the quality-check to remove any genomic 
remnants. A TURBO DNA-free kit from Ambion was used for this purpose. A protocol from 
the manufacturer was used. First 0.1 volume (E.g. 25 µl sample volume was added 2.5 µ 
DNAse buffer, volume of each sample varied) of DNase buffer and 0.5 µl of DNase were 
added to each sample. The solution was mixed, centrifuged and incubated in a heating-block 
at 37OC for 20 min. After this, 0.1 volume of DNase inactivating reagent was added and the 
inactivation was done by flicking the tubes 2-3 min in RT. Then the samples were centrifuged 
for 3 min at 10 000 x g before the supernatant was removed and frozen at -80OC. 









Reverse transcriptase and Q-Real-time Reverse transcriptase polymerase chain reaction 
cDNA was synthesized using Taqman RT-reagents after a protocol from a producer in 
GeneAmp PCR system 2700.  24 µl of RT-mastermix and 1 µl (50 ng) of RNA sample was 
mixed in a 0.2 ml 8-tube thermo strip and the following termic parameters were used. 
• 25OC – 10 min 
• 48OC – 30 min 
• 95OC – 5 min 
The cDNA product was kept at -20OC 
Q-real-time RT-PCR was performed using duplicates and read using an ABI prism 7000 
sequence detecting system. Following cycles were used:  
• 1. Stage: 50OC 2 min, 1 cycle  
• 2. Stage: 95OC 10 min 1 cycle  
• 3. Stage: 95OC for 15 sec, 60OC for 1 min,  40 cycles  
• 4. Stage: 95 OC for 15 sec, 60OC for 20 sec, 950C for 15 sec. 
Every PCR reaction consisted of 25 µl PCR mix, including, cDNA, sybr green PCR 
mastermix, water, forward and reverse primers (5µM) for IL-1β, TNF-α1, IL-8 and IL-6 
respectively.  
 
Table 2: Information of the primers used in detection of selected genes.  Primers delivered from Operon 
(Operon Biotechnologies GmbH, Germany) 
 
Target m-RNA Primer Name/Accesion no Sequence Tm Amplicon
IL-1β AsIL-1b AY617117 CAAGCTGCCTCAGGGTCTG 83 101 (bp) 
  AsIL-1b AY617117 CGCCACCCTTTAACCTCTCC 83 101 (bp) 
            
TNF-α1 AsTNF-a1 AY929385 TTGCTAGACTTTCCCACTGCC 79 101 (bp) 
 AsTNF-a1 AY929385 TCCATGTCGCCAGTTGTCAT 79 101 (bp) 
            
IL-6 AsIL-6 TC61685 TGGTGGTGGAGCAAAGAGTCT 82 101 (bp) 
  AsIL-6 TC61685 GGAGGAGTTTCAGAAGCCCG 82 101 (bp) 
            
IL-8 AsIL-8 DW53092  TGGAATGATTCCCCTTCTTCA 80 104 (bp) 
 AsIL-8 DW53092  GCAACAGCGGTCAGGAGATT 80 104 (bp) 









To quantify the result a two-fold dilution standard curve of each of the four primers (IL-1β, 
IL-6, IL-8 and TNF-α1) and the standard 18S was performed. The same cDNA sample was 




Efficiency calculations: E = 10^ (-1/slope) 
 
 









Table 3: Slope, r2 and efficiency for the primers. These numbers were calculated from the standard-curves 
(see fig. 5) 
Target Gene Slope r2 % E 
IL-1β -5,5038 0,9972 1,52 
TNF-α1 -3,1981 0,9907 2,05 
IL-6 -4,5647 0,9652 1,65 
IL-8 -3,7564 0,9934 1,84 
18S -3,3415  0,9987 1,99 
 


































Figure 4: Standard curve for the IL-1β (pink), IL-6 (yellow), IL-8 (green), TNF-α1(black) and 18S (red) 
primer. The log quantities of cDNA plotted against Ct cycles gives us the calculation numbers for primer 







The relative ratio of expression for the target gene was calculated from primer efficiency and 
Ct-value of the unknown sample versus the respective sample of gene of reference (18S)[72]: 
 
EtargetΔCt target (calibrator-sample) 
R      =                                        -------------------------------------------- 
Ereference ΔCt target (calibrator-sample) 
 
The RNA-samples were checked for any genomic contamination by running pure RNA 















There are different approaches to monitoring DNA synthesis; we have in this master thesis 
used Sybr green. Sybr green is a dye that will bind to all double-stranded (ds) DNA, and gives 
out a bright fluorescence.  
Since Sybr green binds to any double-stranded DNA it can be less specific than other methods 
used to monitor PCR synthesis. To ensure the specificity of the result one examines the 
melting curve of the products (Fig. 5). The melting point of DNA double helix depends upon 
its nucleotide composition, and the primers should have an specific melting-point unless there 
are contaminations. I.e. the samples of all products run on one primer, e.g. IL-1β, should have 
the same melting point at 83OC. If the peaks are not similar, this can suggest contamination, 
mispriming or primer-dimer formations. A primer-dimer artefact is due to that the primers can 
sometimes anneal to themselves and create small templates for PCR amplification. 
Mispriming is a result of cDNA made due to annealing of the primers to complementary, or 




Figure 5: Disassociation/melting point (Tm) plot. The rate of change of the relative fluorescence units 
(RFU) with time (T) (-d(RFU)/dT) on the Y-axis versus the temperature on the X-axis. Left: Tm curve for 
18S.  The strands are showing similar melting points. Right: Faulty detection of primer-dimer artefacts 
are possible using sybr green, and this will give lower and fluctuated melting points due to shorter DNA 
strands, as shown here. Compared to the collective peak to the right. 
 






















3.1. PLGA characterization 
3.1.1. Surface characterization 
To visually check the surface of PLGA particles, a Scanning Electron Microscope picture 
(SEM) was obtained (Fig.6 (left)). The particle size of the PLGAs, in SEM-imaging, was 
variable. The particles seemed to have smooth surfaces. By morphological examination the 
particles consisted of a mix of circular and more irregular forms. The irregular forms were 
probably due to particles aggregation. However the spherical forms were dominant. 
 
 
Figure 6: Left: PLGA particles Scanning Election Microscope image. Right: size distribution. PLGA 
particle distribution is measured by the use of Photon Correlation Spectroscopy (PCS). The mean 
diameter according to a Gaussian distribution is 325.8 nm.  
 
3.1.2. Size distribution of PLGA particles 
Size distribution was measured using Photon Correlation Spectroscopy (PCS). Figure 6 (right) 
shows a Gaussian distribution (normal distribution) of PLGA particles using PCS 
measurements. The bulk particles were around 300 nm, as the peak in figure 6 indicates. We 












3.2. PLGA particles associated with ip cells after ip injection 
To visually study the PLGA particles in the peritoneal cavity cells, we obtained samples 
consisting of ip-cells at each sampling time (2, 4, 7, 14 and 30 days post-injection). Samples 
from all three experimental groups and the control group injected with saline were examined. 
PLGA particles associated to or were within ip-cells up to 14 days post-injection were 
observed, but no particles were seen in the other obtained experimental groups (Fig.7) 
Samples taken after 30 days post-injection showed no PLGA particles. Any characterizations 
of these ip-cells were not performed, and a quantitative measurement on the number of 
particles per cells was not done. 
     
 
        
Figure 7: PLGA particles associated to or within intraperitoneal (ip)-cells after injection. Upper left: close 
up PH image of ip-cells sampled from group 4 (mixture of LPS and PLGA) at day 2 post-injection. Upper 
right: Fluorescence micrograph of the upper left cells. The 6-coumarin labelled particles appeared bright 
green by fluorescence microscopy. Below left: PH image of ip-cells from fish injected with PLGA/LPS at 
day 14 sampling. Below right: Fluorescence micrograph of the below left cells. As in the picture above we 









3.3. Tissue distribution of PLGA particles after i.v. injection 
PLGA particles may loose their spherical morphology and may acquire structures that may be 
difficult to observe by means of histological work-up of formalin fixed tissues and tissue 
sections. As such, we tried another dehydration procedure that replaced isopropanol with 
xylene during the preparation of tissue sections. No PLGA particles were observed in any 
tissue sections whether they were treated with xylene or isopropanol. Control sections 
obtained from fish injected with saline did not contain PLGA particles. However some PLGA 
particles were observed in blood 2 days after i.v. injection (not shown).  
 
3.4. Cytokine expression after ip injection   
The integrity of RNA isolated from intraperitoneal cells was, in some samples, poor as 
assessed by gel-electrophoresis. Also, the amounts of RNA isolated in a limited number of 
samples were low/not detectable. These RNA samples were not taken further to real-time 
PCR.  
 
3.4.1. Expression of IL-1β 
IL-1β is a pro-inflammatory cytokine, important in the acute-phase response. IL-1β will be 
secreted from macrophages at the infection site in response to different factors TNF-α1, LPS 
and many others. IL-1β exhibits a wide range of inflammation-inducing actions, i.e. 
production of other cytokines like IL-8 and IL-6, and it often co-works with TNF-α1. As such, 
the transcription of IL-1β was measured in samples (head kidney leucocytes, spleen and 
peritoneum) obtained from fish intraperitoneally injected with PLGA, LPS, and PLGA plus 
LPS. Control fish was injected with saline.  
Expression of IL-1β was generally low in all samples obtained from either saline, PLGA, LPS 
and PLGA/LPS injected fish (Fig. 8). In the peritoneum all experimental groups show 
expression levels below the baseline level. In the liver fish injected with PLGA and a 
PLGA/LPS mix are showing a 2-fold increase in transcription level compared to the baseline 
level. The group injected with PLGA shows a slight up-regulation in expression of IL-1β, just 

































Head kidney leukocytes                                        Liver                                          Spleen                                     Peritoneum
  
Figure 8: Relative expression of IL-1β relative to 18S in head kidney leucocytes (purple), liver (blue), 
spleen (green) and peritoneum (orange) after injection of saline, PLGA, LPS and a PLGA/LPS mix. The 
results were based on values from two parallel fish, and day 2, 4, 7, 14 and 30 results have been merged 
together. 
 
Similarly, the time-course experiment for IL-1β showed that a peak expression of IL-1β in 
head kidney leukocytes from the saline injected controls approximately 14 days post-
injection. However, there was a transient increase of IL-1β expression in samples from PLGA 
injected fish from day 14 to day 30 (Fig. 9) 
 
 



















Figure 9: Time-course expression of IL-1β in head kidney leucocytes at day 2, 4, 7, 14 and 30 post 
injection, values were relative to expression levels of 18 S. 
  
 
The time study of IL-1β expression in head kidney macrophages (Fig. 9) shows in general a 
low transcript level. Except from the control-group (SW) there is relatively no expression in 
either of the experimental groups. The highest level was from the 5th sampling, day 30 in 









As observed from head kidney cells, the expression of IL-1β in liver from saline injected fish 
was higher compared to the other groups and peaked at day 7 post-injection (Fig. 10). 
However the amount of IL-1β mRNA in liver at day 2 samples from fish injected with 
PLGA/LPS was higher than the corresponding saline controls (Fig. 10). 
 



















Figure 10: Time-course expression of IL-1β in liver at day 2, 4, 7, 14 and 30 post injection, values were 
relative to expression levels of 18 S. 
 
 
In contrast to the head kidney cell and liver expression of IL-1β, the spleen expression of IL-
1β in samples from PLGA and PLGA/LPS 2 days post-injection were higher than the 
expression levels in the controls injected with saline. The expression levels in spleen samples 
from the other groups were similar throughout the study (Fig. 11). 
 
 



















Figure 11: Time-course expression of IL-1β in spleen at day 2, 4, 7, 14 post injection, values were relative 











The expression of IL-1β in samples obtained from saline injected fish peaked at day 4 and 7 
post-injection. The expression levels of IL-1β in samples from PLGA, LPS and PLGA/LPS 























Figure 12: Time-course expression of IL-1β in the peritoneum at day 2, 4, 7, 14 and 30 post injection, 






3.4.2. Expression of IL-6 
IL-6 is a cytokine that is central in the acute phase response. In contrast to the expression of 
IL-8, IL-1β and TNF-α1 in liver, IL-6 was not significantly expressed in liver of fish injected 
with PLGA, LPS, PLGA/LPS mix or saline. For these groups the transcript levels of IL-6 in 
the time-point samples (two parallel samples pooled together) were not very different from 
each other (Fig. 13). However the control transcript level in head kidney leucocytes was 
higher than the levels in samples obtained from fish injected with PLGA, PLGA/LPS mix and 
































Head kidney leucocytes                                                                         Spleen                                                                           Peritoneum   
Figure 13: Expression of IL-6 relative to 18S in head kidney leucocytes (purple), spleen (green) and 
peritoneum (orange) after injection of saline, PLGA, LPS and a PLGA/LPS mix. The results were based 























Figure 14: Time-course expression of IL-6 in the peritoneum at day 2, 4, 7, 14 and 30 post injection, values 




As can be observed from figure 14, the expression level of IL-6 in peritoneal cells at day 2 
and 4 obtained from fish injected with LPS and PLGA, respectively, were approximately four 
fold higher than in cells from fish injected with the PLGA/LPS mix. The relative expression 
of IL-6 in peritoneal cells controls increased from day 7 to day 14, whereafter reading a 





























Figure 15: Time-course expression of IL-6 in head kidney leucocytes. Cells from the head kidney were 
sampled from fish injected with saline (SW), PLGA, LPS and a PLGA/LPS mix at day 2, 4, 7, 14 and 30 
post-injection. Values were relative to expression levels of 18S. 
 
 
In contrast to expression levels of IL-6 in peritoneal cells, peak expression of IL-6, in head 
kidney leukocytes, was observed at day 7 for PLGA injected fish. Increasing levels of IL-6 
transcripts were observed in cells injected with PLGA/LPS mix which peaked at day 14. 
Transcriptlevels in the saline injected fish increased from day 14 to day 30. The expression of 

























Figure 16: Time course- expression of IL-6 in spleen. Tissue from the spleen was sampled from fish 
injected with saline (SW), PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, and 14 post-injection. Values 










The expression level of IL-6 in the spleen was highest in fish injected with PLGA and a 
PLGA/LPS mix followed by saline controls and LPS at day 2. However, LPS induced 
relatively high IL-6 expression in spleen obtained from fish at day 4 post-injection. Then, the 
expression levelled off and was similar to the transcript levels in the other groups.  
 
3.4.3. Expression of IL-8  
IL-8 is a chemokine important in the acute phase response attracting leukocytes to the 
inflammatory site. As such, the transcript levels of IL-8 were measured in different tissue and 
cell samples obtained from fish injected with the abovementioned particles with and without 
LPS or LPS alone. In head kidney leucocytes the expression level of IL-8 (two pooled 
parallels) was highest in samples from PLGA/LPS injected fish. The same was observed in 
spleen. Liver and peritoneal cell the transcript levels of IL-8 in fish injected with PLGA were 
higher than the corresponding levels in the other treatment groups. The IL-8 mRNA levels in 
LPS injected fish were similar or lower compared to control samples. The liver contained 





























     Head kidney leucocytes                                Liver                                                       Spleen                                       Peritoneum
 
Figure 17: Expression of IL-8 relative to 18S in head kidney leucocytes (purple), liver (blue), spleen 
(green) and peritoneum (orange) after injection of saline, PLGA, LPS and a PLGA/LPS mix. The results 































Figure 18: Time-course expression of IL-8 in spleen. Tissue from the spleen was sampled from fish 
injected with saline (SW), PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, and 14 post-injection. Values 
were relative to expression levels of 18S. 
 
Interestingly, the expression levels of IL-8 in the spleen of fish injected with a PLGA/LPS 
mixture was high at day 2 compared to the mRNA levels in the other samples (Fig.18). This 
peak was followed by a decrease to a base level before a minor increase to day 14. The 
expression levels of IL-8 in the other samples were relatively low throughout the study period, 
except for spleen from LPS injected fish at day 14. The expression levels of IL-8 in the other 
samples obtained from PLGA and saline injected fish, were relatively low throughout the 
study period. 
 


















Figure 19: Time-course expression of IL-8 in liver.  Tissue from the liver was sampled from fish injected 
with saline (SW), PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, and 14 post-injection. Values were 
relative to expression levels of 18S. 
 
The liver expression levels of IL-8 in fish injected with LPS and saline peaked at day 7 in 









expression was observed at day 4 and 2 post-injection, respectively. These peaks 
corresponded to an approximately 16-fold increase compared to a baseline value. The liver 
samples from PLGA injected fish showed a steady increase of IL-8 with respect to transcript 
levels from day 7 to day 30. While the transcript levels peaked at day 2 to 7 in liver samples 
obtained from fish injected with saline, PLGA or LPS, late peak transcription levels were 
found in the peritoneum (day 14 post-injection) (Fig. 20). Cells from PLGA and saline 
injected fish displayed increased IL-8 transcript levels compared to cells from LPS and 

























Figure 20: Time-course expression of IL-8 in peritoneum. Cells were sampled from fish injected with 
saline (SW), PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, and 14 post-injection. Values were relative 

































Figure 21: Time-course expression of IL-8 in head kidney leucocytes.  Cells were sampled from fish 
injected with saline (SW), PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, 14 and 30 post-injection. 






The head kidney leucocyte expression of IL-8 of fish injected with a PLGA/LPS mixture did 
not show a peak expression of IL-8, but was increasing throughout the study period. This was 
in contrast to the expression profile of IL-8 in cells obtained from saline injected fish were 
peak expression was observed at day 14. The amounts of IL-8 mRNA found in the leucocytes 
from fish injected with LPS and PLGA were low during the 30-day period. 
 
 
3.4.4. Expression of TNF-α1 
In addition to IL-1β, IL-6 and IL-8, TNF-α1 is also considered to be an acute-phase cytokine 
with pro-inflammatory effects. The relative expression of TNF-α1 in the current study was 
generally highest in the liver and spleen. However peritoneal cells also contained significant 
amounts of TNF-α1 transcript levels (Fig. 22) that contrasted to the head kidney leucocytes. 
Overall, the liver and spleen transcripts of TNF-α1 were higher in PLGA/LPS injected fish 
compared to the saline injected salmon. PLGA injection induced TNF-α1 transcription in 
spleen and peritoneal cells however, the levels of TNF-α1 mRNA in head kidney cells 






































Head kidney leucocytes                          Liver                                            Spleen                                  Peritoneum  
Figure 22: Expression of TNF-α1 relative to 18S in head kidney leucocytes (purple), liver (blue), spleen 
(green) and peritoneum (orange) after injection of saline, PLGA, LPS and a PLGA/LPS mix. The results 



























Figure 23:  Time-course expression of TNF-α1 in head kidney leucocytes. Cells sampled from fish injected 
with saline (SW), PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, 14 and 30 post-injection. Values were 
relative to expression levels of 18S. 
 
 
The relative expression of TNF-α1 in head kidney leukocytes were low at almost all time-
points except at day 14 and 30 where cells from saline injected fish displayed relatively high 


























Figure 24: Time-course expression of TNF-α1 in liver sampled from fish injected with saline (SW), PLGA, 
LPS, and a PLGA/LPS mix at day 2, 4, 7, 14 and 30 post-injection. Values were relative to expression 
levels of 18S. 
 
However, the liver from PLGA/LPS and LPS injection groups (Fig. 24) showed relatively 
high expression of TNF-α1 mRNA 2 days post-injection where latter substance induced a 
peak expression also at day 14 post-injection. A peak expression was also observed in liver at 
day 7 for saline injected fish. 
 















Figure 25: Time-course expression of TNF-α1 in spleen sampled from fish injected with saline (SW), 
PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, and 14 post-injection. Values were relative to expression 
levels of 18S. 
 
As observed with respect to liver expression of TNF-α1 in PLGA/LPS injected fish the spleen 
contained also relatively high amounts of TNF-α1 mRNA with a main peak at day 2 that 
decreased to baseline, followed by an increase throughout the study (Fig. 25). An injection of 
LPS induced a peak transcription of TNF-α1 at day 4, and levelled off to base-line value at 









with PLGA decreased from a near 8-fold at day 2 to base-line value at day 14. The controls 
contained highest level of TNF-α1 transcripts at day 7. 
 



















Figure 26: Time-course expression of TNF-α1 in peritoneum sampled from fish injected with saline (SW), 
PLGA, LPS, and a PLGA/LPS mix at day 2, 4, 7, 14 and 30 post-injection. Values were relative to 
expression levels of 18S. 
 
As for spleen, the transcripts level of TNF-α1 in peritoneal cells from fish injected with LPS 
peaked, with a 9-fold increase, early post-injection (Fig.26). This peak was followed by a 
decrease to day 14. The LPS induced TNF-α1 mRNA expression was relatively stable with a 
small peak at day 2 post-administration. Saline injection also induced TNF-α1 gene 
expression in peritoneal cells that peaked at day 14 post-injection. Minor changes with respect 
to relative expression levels were found in cells from the other treatment groups. 
  
 
3.4.5. Comparison of TNF-α1, IL-1β1, IL-6 and IL-8 expression  
While most of the figures 8-26 present a detailed time-course expression of one cytokine 
mRNA in experimental groups, I wanted to present an overall view of the time-course of all 
cytokines expressions in each experimental group and tissues/cell sample. As such, some 
details may be difficult to observe in figures 27-38. 
When comparing the expression levels of  the different cytokine mRNAs, within the 
experimental group that were injected with PLGA, in head kidney leukocytes, the overall 
pattern shows a general increase in expression levels from day 2 throughout the study, except 
for IL-8 saline control, that peaked at day 14 post-injection. Overall, the control samples 



































Figure 27: Time-course expression of IL-1β, TNF-α1, IL-6, IL-8 in head kidney cells sampled from fish 
injected with saline (control) and PLGA at day 2, 4, 7, 14 and 30 post-injection. Values were relative to 
expression levels of 18S. 
 
In contrast to the relative high head kidney cell expression values of saline injected control 
fish compared to PLGA injected fish (Fig. 27), an injection of PLGA induced spleen IL-1β 
TNF-α1,  and IL-6 day 2 transcription  levels that were relatively higher than in the respective 
controls (Fig. 28). At a later time-point (day 7) the general pattern was the opposite, i.e. the 
respective control fish showed higher spleen transcript levels of the genes than their PLGA 
injected counterparts. While early (< day 7) transcription levels of genes in head kidney cells 
was present, there was a delayed peak in transcriptions of spleen IL-1β and IL-8 (day 7) post-
injection of PLGA (Fig. 28). This applied also to spleen IL-1β transcript level obtained from 
saline injected fish (Fig. 27). 
 























Figure 28: Time-course expression of IL-1β, TNF-α1, IL-6, IL-8 in spleen sampled from fish injected with 
































Figure 29: Time-course expression of IL-1β, TNF-α1, and IL-8 in liver sampled from fish injected with 






In liver, the control samples obtained from fish injected with saline contained higher amounts 
of cytokine mRNAs at day 7 post-injection than their PLGA injected mates. In exception, the 
expression level of IL-8 at day 30 was higher than the IL-8 expression in liver from saline 



























Figure 30: Time-course expression of IL-1β, TNF-α1, IL-6, IL-8 in peritoneum sampled from fish injected 
with saline (control) and PLGA at day 2, 4, 7, 14 and 30 post-injection. Values were relative to expression 










Peculiarly, the day 14 transcript levels of TNF-α1, IL-1β and IL-6 in peritoneal cells of fish 
injected with saline were higher than in cells from fish injected with PLGA. In general, the 
opposite was observed in the day 4 samples where the transcript level of TNF-α1, IL-6 and 
IL-8 in cells were higher than their respective controls (Fig. 30). 
 
 























Figure 31: Time-course expression of IL-1β, IL-6, IL-8 and TNF-α1 in head kidney leucocytes sampled 
from fish injected with saline (control) and LPS at day 2, 4, 7, 14 and 30 post-injection. Values were 
relative to expression levels of 18S.   
 
 
Compared to spleen and liver where early peaks (day 2 to 7) with regards to transcript levels 
were observed, the peritoneal cell (Fig. 29) and head kidney leukocyte transcript levels of the 
genes under study peaked later (day 14) (Fig. 31). In the head kidney cells, the day 14 
transcript level of IL-8, IL-1β and TNF-α1 were higher in saline injected fish compared to the 
corresponding PLGA injected fish. This was the case also in the 30 day samples for IL-6 and 
TNF-α1 where the controls contained higher levels of transcription levels of transcripts than 
their counterparts. In spleen (Fig. 32) there was a peak expression of all of the target genes at 
day 4 sampling, with TNF-α1 exhibiting a 6 fold-increase in expression levels compared to a 
baseline-level, followed by IL-8, IL-6 and IL-1β at decreasing order, and expression levels in 
their respective controls were lower. at day 4 sampling. These differences were not 
pronounced in day 7 samples, this also applied to sample obtained from fish injected with 


































Figure 32: Time-course expression of IL-1β, IL-6, IL-8 and TNF-α1 in spleen sampled from fish injected 
with saline (control) and LPS at day 2, 4, 7 and 14 post-injection. Values were relative to expression levels 
























Figure 33: Time-course expression of IL-1β, IL-8 and TNF-α1 in liver sampled from fish injected with 




Generally expression of IL-8 was higher in liver (Fig. 33) compared to spleen (Fig. 32), and 
also a delayed peak in comparison with the spleen was observed, with a 15-16 fold increase in 
expression at day 7 sampling for samples obtained from fish injected with LPS and saline, 
before a rapid decrease to below a baseline level at day 14 sampling. Expression of IL-8 in 
fish injected with saline is exhibiting the highest level, of all genes analysed, through the 
time-course study in liver, with a peak at day 7 sampling.  Compared to the spleen, the 
expression levels of TNF-α1 in liver was lower, and also showed a different profile, with a 









day 14.  
Expression of IL-1β peaked at day 4, however it rapidly decreased to levels more or less equal 
to a baseline level at day 14 sampling and stayed low thereafter. Fish injected with saline also 
showed a peak at day 7 in expression levels of IL-1β. 
 























Figure 34: Time-course expression of IL-1β, IL-6, IL-8 and TNF-α1 in peritoneum sampled from fish 
injected with saline (control) and LPS at day 2, 4, 7, 14 and 30 post-injection. Values were relative to 
expression levels of 18S.   
 
Expression of cytokines in the peritoneum post-injection of LPS (Fig. 34) showed a peak in 
amounts of IL-6 mRNA transcripts, followed by TNF-α1, and IL-8 at day 2 sampling. IL-1β 
exhibited levels not significantly different to a baseline-level through the whole time-course 
study. However, expression of TNF-α1, IL-6, IL-8 levels in fish injected with saline peaked at 
day, and the peak levels exceeded the peak -levels of the experimental LPS injected fish at 
day 2 sampling. 
 



















Figure 35: Time-course expression of IL-1β, IL-6, IL-8 and TNF-α1 in spleen sampled from fish injected 
with saline (control) and a PLGA/LPS mixture at day 2, 4, 7 and 14 post-injection. Values were relative to 










Expression levels of TNF-α1 were high in fish injected with PLGA/LPS mixture at day 2 
sampling, compared to fish injected with saline, both in spleen (Fig. 35) and liver (Fig. 36). In 
general, all expression levels of cytokines from the experimental group showed a peak at day 
2 sampling in spleen, with TNF-α1 being the highest, and IL-8, IL-1β and IL-6 following in 
that order. In spleen TNF-α1 transcript levels dropped below a baseline level at day 4 
sampling before a continuous increase in expression levels to latest sampling point at day 14. 
The target genes all decreased to a baseline level at day 7 and stays there throughout the time-
course study. 
In liver (Fig. 36) the same decrease in transcript levels in the PLGA/LPS experimental group 
was observed. However expression levels of IL-8, IL-1β and TNF-α1 rose to a peak by day 7 
in sample from saline injected fish. The amounts of cytokine transcripts in PLGA/LPS and 
saline injected fish were low from day 14 to 30.  
 




















Figure 36: Time-course expression of IL-1β, IL-8 and TNF-α1 in liver sampled from fish injected with 
saline (control) and a PLGA/LPS mixture at day 2, 4, 7, 14 and 30 post-injection. Values were relative to 
expression levels of 18 S. 
 
In head kidney leucocytes two expression profiles were observed; the expression level of IL-8 
increased (day 4 to 30) to a level of 16 fold higher compared to baseline level. Except from 
IL-8 transcript levels, there seemed to be low expression of the other cytokines studied 
irrespective whether they were injected with PLGA/LPS or saline. Expression levels in fish 


































Figure 37: Time-course expression of IL-1β, IL-8, IL-6 and TNF-α1 in head kidney leucocytes sampled 
from fish injected with saline (control) and a PLGA/LPS mixture at day 2, 4, 7, 14 and 30 post-injection. 
Values were relative to expression levels of 18 S.  
 
 
























Figure 38: Time-course expression of IL-1β, IL-8, IL-6 and TNF-α1 in peritoneum sampled from fish 
injected with saline (control) and a PLGA/LPS mixture at day 2, 4, 7, 14 and 30 post-injection. Values 
were relative to expression levels of 18 S.  
 
As seen for most cytokines studied in head kidney leucocytes (Fig. 37), there was a peak in 
expression level in peritoneum (Fig. 38) of IL-1β, IL-6, IL-8 and TNF-α1 at day 14 sampling 
from fish injected with saline. Expression levels of IL-6 at day 2 sampling showed a 2-fold 
increase, and compared to 18S expression throughout the time-course study expression levels 
were at baseline levels. Transcript levels of IL-8 and TNF-α1 were just above a baseline level 
at day 2 and 4  post-injection respectively, however, all levels declined to under baseline level 












In fish there has previously been an attempt to administer antigen-containing PLGA particles 
orally (by intubation) [47], and the study concluded that  PLGA particles were worth further 
investigating as an antigen delivery vehicle as the particles seemed to ensure that a larger 
amount of intact antigen (protein in this case) reached into the system, after passing through 
the stomach. Beside this, no reports are available using PLGA as vaccine carriers for use in 
aquaculture. 
The overall aim of this thesis was to investigate the expression of pro-inflammatory 
cytokines, important in the early stages of inflammation, elicited by PLGA particles in LPS 
solution and/or alone. Repeatedly, PLGA particles as antigen carrier has been evaluated and 
high potencies in activating the adaptive immune response in mammals [29, 84]. However, to 
my knowledge there are no studies that have addressed the inflammatory response of PLGA 
particles per se by means of gene transcript analysis of acute phase products. This raised the 
following question: Do PLGA particles elicit immune responses on their own without 
antigens adsorbed onto or encapsulated inside? And does an ip injection of LPS together with 
PLGA induce a response higher than injections of PLGA or LPS alone. 
Mammalian dendrittic cells, the main APC, showed an adjuvant-like maturation with 
expression of MHC class II and expression of costimulatory molecules on DC`s stimulated 
with PLGA particles [89]. The exact way PLGA is stimulating DC maturation in mammals is 
not known, like the LPS pathway to stimulate macrophage activation through the TLR4 is 
[34]. The level of maturation in DC`s was not at the same level as by LPS alone, but scontain 
macrophages (APC), whether they can respond to PLGA and LPS as shown for mouse DC 
[89] remains unknown. 
 
4.1. PLGA in association with ip-cells  
A prerequisite for using PLGA particles for intracellular delivery of antigens, their actual 
uptake by fish phagocytic cells (macrophages), the main APC in fish [20, 63]. PLGA have 
shown to be phagocytosed by a number of mammalian cells [65] by various endocytic routes, 
like phagocytosis, pinocytosis or by receptor-mediated endocytosis, and the process seems to 









particles injected intraperitoneally have been taken up by phagocytic cells, the particles were 
seen associated or were inside the cells up to 14 days post-injection. Because the present 
findings are based on a limited number of fish, further experiments have to be performed to 
assess whether particles are also present within cells beyond 14 days. Nevertheless, the results 
achieved may indicate that PLGA particles offer novel delivery systems in fish by 
intraperitoneal administration, for a prolonged antigen release. There are reasons to believe 
that the cells associated with PLGA particles after 2 days are mainly neutrophils since studies 
have shown a great influx of neutrophils 24-48 h post-injection of bacteria in rainbow trout, 
about 50 times the macrophage population [2, 23]. See introduction for the cell distribution in 
a normal state. However the cell type responsible for uptake of PLGA has to be characterized 
in future studies. After injection of bacteria, a resting population of peritoneal cells was re-
established within 14 days. Neutrophils have been shown to have phagocytic ability, ingesting 
invading microbes and then undergo cell apoptosis[1, 2]. However no conclusions are made in 
this study, other than, PLGA are attached to and are within ip-cells. As such, the phagocytic 
process itself may induce physiological changes such as modulation of acute phase cytokine 
transcript levels. 
 
4.2. Cytokine m-RNA transcripts 
Looking at the transcription level of pro-inflammatory cytokines, would provide us a more 
insight to which extent PLGA particles induce inflammation. Since no other studies of PLGA 
and proinflammatory responses in fish have been published, there were few previous studies 
to rely on. However, it is a fact that TNF-α1 and IL-1β, IL-6 and IL-8 are among the first 
cytokines produced in fish and mammals [5, 79], thus these cytokines are trustworthy markers 
in pro-inflammatory studies on fish. Biological studies of IL-1β have shown that transcript 
levels can be elevated by aroA− Aeromonas salmonicida LPS stimulation of leucocytes in 
rainbow trout, and inhibited by cortisol (stress-hormone) and low temperatures in vitro [90]. 
In fish IL-6, IL-8 and TNF-α expression is known to also be induced by exposure to LPS  in 
vitro [32, 35, 46]. Taking these results together with observed cytokine profiles observed in 
mammalian species, IL-1β, TNF-α, IL-6 and IL-8 are all acute phase and are applicable to use 
as acute phase response markers. 
4.2.1. Tools for real time-PCR 









a low efficiency could be due to a hairpin structure in the annealing position of the primer 
reduces the amount of cDNA available for the polymerase. Poor quality RNA obtained from 
some of the samples in the current experiment were not brought to the real-time PCR. Since 
all primers, including those for 18S were added to the same cDNA preparation a poor quality 
cDNA may affect all the genes in study. Bad primer efficiency could also be due to the 
binding of other structures that are similar to the target genes (personal communication, Marie 
Løvoll). There are identified two IL-1β genes in rainbow trout [73], and perhaps can this be 
the case also in Atlantic salmon.  
However, in this study we used a relative calculation-method [72] where transcript levels are 
relative to a standard (18S), thus the results can still be used to assess difference in gene-
expression among the selected genes and  in between tissues. There were indications of that 
injection of PLGA particles per se elicited low levels of all cytokines in head kidney 
leucocytes and liver. In spleen however, TNF-α1, IL-1β and IL-6 expression levels were 
elevated at early samplings (day 2), and also in the peritoneum (TNF-α1 is elevated at day 4 
and IL-8 at day 14). IL-8 is known to be produced in response to IL-1 and TNF [15], therefore 
a link between the production of IL-1β, TNF-α1 and chemokine production could be 
suggested in this case. 
 
4.2.2. mRNA transcript levels post ip injection 
Results from LPS injected fish showed no detectable levels of IL-6 in liver in any 
experimental groups points (PLGA, LPS and a mixture of PLGA/LPS). Correspondingly, a 
study on rainbow trout [35] showed no presence of IL-6 mRNA in liver from untreated fish. 
Highest level of IL-6 in rainbow trout was in the ovary. Thus the number of particles or the 
amount of LPS injected in this study may not have been sufficient to induce an IL-6 
expression in liver. 
 IL-6 holds many functions, and recent studies revealed that in acute inflammation, IL-6 
decrease neutrophils migration, as described earlier, but increased monocyte/macrophage 
recruitment, leading to a resolution of inflammation and initiation of an immune response 
[40]. If we look at the expression level in peritoneum after LPS injection, IL-6 was elevated at 
day 4 sampling, which could be an indication of a inflammation that may induce leucocyte 
migration. However, the gene for IL-6 was first characterized in Japanese pufferfish Fugu 









mammalian is not clear yet. 
High levels of TNF-α1 were seen at day 4 in spleen and at day 2 in liver. This may  indicate 
an early first stage elevation that induce high levels of IL-8 in liver first at day 7. As earlier 
mentioned, that production of IL-8 is initiated i.e. by TNF-α1, and any delayed expression of 
IL-8 may be due to this.  
Results from fish injected with a mixture of PLGA/LPS showed elevated levels of cytokine 
transcripts at an early stage in spleen and liver, where TNF-α1 transcript levels were highest 
in both tissues, followed by IL-8 and IL-1β, IL-6 only elevated in the spleen. The expression 
seemed to be limited to early phases, except from TNF-α1 that in spleen was elevated again at 
day 14, followed by a small elevation of IL-8. TNF-α genes have been characterized and 
studied expression of in rainbow trout and Japanese flounder [32, 45]. In trout the TNF-α 
seems to be divided in two genes, as known to be the case in other molecules of salmonids. 
TNF-α seem to be constitutively expressed in gills and head kidney of trout as well as 
leucocytes in Japanese flounder. In vitro studies show up-regulation by stimulation by LPS, 
paramethoxyamphetamine (PMA), and trout rIL-1β receptor. Maximal expression 3-4 h post-
stimulation [45].  The temperature of fish surroundings in this experiment was around 4OC, 
and comparison to time-line from in vitro studies can not be made. The temperature is low, 
and generally the peaks of cytokine mRNA transcript levels are around 1-4 days. One day is 
also included even though no samplings was made prior to day 2, however the peak in 
expression in especially the spleen seem to be descending at day 2 samplings to day 4, 
indicating a possible peak at time-points prior to 48 h. From these data there might be 
implications of an acute phase response in salmonids ending at day 2-4.  
 
4.2.3. Experiment set-up and materials 
The spleen and liver, which are technically easy to sample, have in overall showed more 
reliable results that the current real-time  Hence the results from peritoneum and head kidney 
leucocytes were not easy to explain at all time, and in some cases, no expression levels above 
18S were observed. In addition, the molecular features displayed by different LPS may result 
in different transcription profiles. As such in vivo expression studies of IL-1β and IL-8 in 
haddock done by Corripio- Miyar, 2006, gave a good presentation of the importance of LPS-
source. The choice of LPS affects the cytokine expression after challenge. IL-1β mRNA 









kidney, spleen, liver and gills were LPS strain dependent, and that some LPS types, did not 
elicit any expression. The same study showed more or less constitutive expression of IL-8 
after stimulation of most of the LPS types. It was suggested that LPS variants showed 
different lipid A structures and therefore also induced different inflammatory responses [21]. 
To ensure comparable results from one experiment to the other, the source of stimulants 
should be kept equal in each experimental set-up. 
More sampling time-points could have been added to the present study, especially the first 4 
days to more closely evaluate fluctuations in mRNA transcript levels. A clear definition of 
when the acute phase response in fish is over aided by cytokine quantification could be 
interesting to evaluate correlation between mRNA transcripts and protein levels. 
Unfortunately, no antibodies against the studied cytokines are commercially available making 
cytokine quantification impossible. 
The relatively high amounts of cytokine expression in saline injected fish could be due to 
individual differences of fish. The samples from tissues and cells were pooled from parallel 
fish, this may partly mask any high or low responders – or visa versa. By running real-time 
PCR on individual samples together with addition of more parallel fish may have improved 
present result. It is a known fact that fish do show large individual differences in immune 
response, thus difference in gene expression levels. The fish in this study were just days prior 
to injection moved from a large tank to a smaller one. The change of environment could 
induce stress that again may elicit up or down regulation of proinflammatory cytokines. In 
addition the handling involved prior to/after injection is a known stress factor for fish. The 
observed high transcripts levels of certain cytokines in certain samples after saline injection 
may be due to such a physiological process.  
RT-PCR detects mRNA transcript levels, but gives no information at protein level [30]. As 
such an apparently early increase of e.g. TNF-α1 transcript level may not directly be 
comparable to physiological effects displayed by TNF-α1 itself as a mature protein. Studies of 
IL-1β mRNA transcription in monocytes versus macrophages after LPS stimulation, revealed 
that the expression level in macrophages was lower (3-folds) than in monocytes, however 
total protein production was higher in macrophages, suggesting a more efficient translation 
[85]. Studies on correlation of protein and cytokine gene expression profiles in human 
subjects after endotoxin challenge, revealed variable correlation between IL-1β, IL-6, IL-8 









regulated on different levels; on gene-levels (transcription), on m-RNA level (translation), and 
on active protein level where stability of protein, presence of receptors and competing ligands 
decides the activity of the cytokine.  
 
4.3. Distribution of PLGA particles 
“Positive” results from a tissue-distribution study would have given clues on which organs, 
tissues and cells that are accumulating the PLGA particles. The whereabouts of the PLGA 
particles is information central to understand their impact on fish immune responses. Why the 
usual processing method for histology did not succeed is not certain. An earlier attempt to 
look at distribution of PLGA particles in salmon (not published) also failed.  This was why 
this new study using isopropanol instead of xylene, was driven through a more or less like a 
pilot-study. Xylene is a powerful solvent that may disrupt the PLGA spheres, and we 
investigated the effects of xylene on PLGA in two ways, first by just placing particles in pure 
xylene which provided particles with lesser fluorescence (leakage), and then a processing 
method replacing xylene with isopropanol. However still after processing without xylene, no 
fluorescent particles could be detected another explanation is that the fluorescence label may 
be release from the particles shortly after injection. However fluorescent particles were found 
in blood after i.v. injection (3 h p.i.) in samples not or processed without xylene – (blood 
smear analysis). This may indicate that tissue processing for histology may disrupt the 
fluorescence labelled particles and impact the analysis of tissue-distribution Otherwise, 
isotope labelling may be a reliable way of achieving quantitative results [55]. When using 
radioactive labelling, precautions must be made, bearing in mind the study animals and the 
work environment. 
 
4.4. Future thoughts 
A different method for isolating IP-cells could have been used, i.e. a method using ergosan 
elicited cells to yield a higher number of cells. The Ergosan method has been used for 
isolating ip-cells prior to transmission electron microscopy [70]. Also by Osmium-labelling 
the particles, as done by Panyam et.al [69] time-course studies can give detailed answers to 
where the PLGA particles end up (this is now under study) in tissues and cells.  
Further studies with cell-culture could give more answers regarding the rate of uptake and if 









important to characterize release-rate of the respective antigen. 
Peritonitis is a known side-effect when oil-adjuvant vaccines are used. There was no sign of 
accretions in the abdominal region of the fish injected with PLGA particles and LPS (results 
not shown). If PLGA particles are showing promising antigen-delivery qualities in the future, 
this is a great advantage compared to oil-adjuvanted vaccines. Still, this was a short study, and 












• Fluorescent PLGA particles are associated with ip-cells up to 14 days post-injection. 
• Conclusion in mRNA transcripts of cytokines being that in spite fluctuating results, 
PLGA seem to elicit pro-inflammatory cytokine production. A mixture of PLGA/LPS 
gives highest expression in most cases. Some genes seem to be easier to study 
transcription of than other, TNF-α being the best in this study. 
• To study the distribution of PLGA particles with ordinary histology-preparation does 












Appendix 1: Production data 
 
OPPRINNELSE - OG PRODUKSJONSDATA FOR FISK PRODUSERT 
VED LANDANLEGGET, HiT. 
 
ART: Laks gr. 1  STAMME: LR standard · GENERASJON:2006 
 
LEVERANDØR: Aqua Gen Norway AS, Hemne AS 
 
 
KAR NR.: 5 
Mottaker: Stine Mari Myren 









Innlagt    29.11.05 4,1 396,3 
Øyerogn - - - 
Klekking 20.12.05 7,3 527,3 






 J F M A M J J A S O N D J F M A
Lys 0/24
:0 
24:0 24:0 24:0 24:0 24:0 24:0/ 
6:18 
6:18 6:18 6:18 6:18 6:18 6:18 6:18 6:18  
T C 8 8/14 14 14 14 14/nat nat nat nat/4 4 4 4 4 4 4  
Fôr - -/SK SK  SK SK SK SK SK SK SK SK SK SK SK SK  
 
 
FÔR: SK = Skretting, EW = Ewos, BI = Biomar, DF = Dana Feed. 
LYS: 24:0 = kontinuerlig lys, 6:18 = 6 t lys og 18 timer mørke, 0:24= kontinuerlig mørke, 
osv.   
 
 
Vaksinasjon: Nei   Dato: …..      Vaksinetype: …. 
Overført antall: 20 stk.          Dato: 28/3-07.                 Størrelse: 57 g.      
Tot. antall: ?? stk. 
 
Status ved levering/merknader: 












Appendix 2: Chemicals and reagent 
Table 4 
Name Manufacturer 
Polyvinylalchohol (PVA) 87-89 % hydrolyzed. Sigma Aldrich 
Poly(D,L-lactide-co-glycolide) 50:50 (PLGA) Sigma Aldrich 
6-coumarin Polyscience inc. 
D-(+)-Trehalose dihydrate (Trehalose)  Sigma Aldrich 
Dichlorotriazinylaminofluorescein (DTAF)  Sigma Aldrich 
Fluorescein-5-thiosemicarbazide Fluka, Sigma Aldrich 
MilliQ water (dH2O)   
Dimetylsulfoxid Fluka, Chemika 
Dichloromethane (DCM) BDH, VWR international Ltd 
Benzokain Apotekprodukt AS 
Sodium Chloride Merck 
Formaldehyde 37 % Merck 
Xylene Merck 
100 % ethanol Arcuss kjemi AS 
96 % ethanol Arcuss kjemi AS 
Paraffin-oil wax Merck 
L-15 medium L-glutamine and L-amino acids Leibowitz, Gibco, Invitrogen™ 
Percoll Invitrogen, PercollTM/RedigradTM, Amersham bioscience
Sodium phosphate dibasic Merck 
Immersion oil Cargille laboratories inc, Kebolab 
Waterfree sodium phosphate dibasic Merck 
Isopropanol Arcus kjemi AS, Norway 
Heparin  2500 U / ml Leofarm AS 
1 x PBS  Gibco, Invitrogen™ 
Diethyl pyrocarbonat BDH, VWR international Ltd 
Qiazol Lysis reagent Quiagen 
TriZol(R) reagent Invitrogen, Amersham bioscience 
Rnasefritt dH2O   
Etidium bromide  Continental lab products 
Mulit ABgarose  Multi ABgene 
Formaldehyde loading buffer Ambion  
Chloroform Merck 
10X taqman RT buffer Ambion  
25mM MgCl2 Ambion  
deoxyBTNs mixture Ambion  
Random hexamers Ambion  
Rnase inhibitor Ambion  
TURBO Dnase (2 units/uL) Ambion  
10X TURBO Dnase Buffer Ambion  
Dnase inactivation reagent Ambion  
Rnalater(R) solution Ambion 
Multiscribe Reverse trancriptase Ambion 











Appendix 3: Solutions 
 
Solutions for isolation of  macrophages  
Stock solution 90% Percoll:  
Stock solution:  
90 ml Percoll 54 % Percoll: 
(10 ml 9 % NaCl) * 59,4 ml Stock solution 
0,4 ml Heparin 40,6 ml L-15 w/Heparin and 2 %FCS 
  
51 % Percoll: 25 % Percoll 
56 ml stock solution 27,5 ml Stock solution 
44 ml L-15 w/heparin and 2 % FCS 72,5 ml PBS w/ 20 U/ ml Heparin 
  
37 % Percoll: L-15 w/ 0,1 % FCS** 
41 ml Stock solution 50 ml: 
59 ml PBS w/ 20 U/ml Heparin 50 ml L-15 
 500µl FCS 
L-15 w /5 % FCS*  
59 ml:  
PBS w/ 20 U/ml Heparin  
* For cod and seawater salmonids to adjust osmolarity 
** In the following referred to as Transport medium  
*** In the following referred to as Incubation medium  
 
Solutions in the making of f/n-PLGA 
*2% PVA  Stock solution 6-coumarin 
 208 µl chloroform   5 mg 6-coumarin 
 98 ml dH2O  (cold) 10 ml chloroform 
2 ml PVA    
Centrifuge at 1000 rpm for 5 min 
Filter through a 0.22 µm filter to remove undissolved 
PVA  Equivalent to 15.8 µg/ml 
*Stock solution- 10% and 20% PVA are diluted from this concentration 
 
Solutions for histology and sampling of organs  
10 % Formalin:  
100 ml 37-40 % Formaldehyde  
900 ml dH2O  
4 g sodium phosphate  
6,5 g water free sodium phosphate   
 













PLGA particles 3, 37um 
NaCl 0,9% 
1 mg/kg*: 
LPS stock (1 mg/ml)  
 
  
*Fish size were of an average of 80 g  
 




1% Agarose gel: 
4 g Multi ABgarose 
3,5 uL Ethidium Bromide 
400 ml TAE buffer  
The Agarose gel is kept at 600C.  
EtBr is always added right before use. 
 
Solutions for total RNA isolation   
 DEPC water: 
 0.5 ml Diethyl pyrocarbonat (DEPC) 
 500 ml Destilled water 
 70%EtOH/DEPC: 
 70 ml Absolute Alcohol 
 30 ml DEPC water 
The DEPC water must be autoclaved before use. 
 
Solutions for reverse transcriptase and Real-time PCR  
RT Mastermix: 
2.5 µl 10 x Taqman RT buffer 
5.5 µl Mg2Cl 
4.0 µl deoxyNTPs mixture 
1.25 µl Random hexamers 
0.5 µl Rnase inhibitor 
0.625 Multiscribe™ Reverse Transcriptase (50U/µl) 
1.0 µl RNA sample (50 ng/ml) 
PCR mastermix 
12.5µl 2 x  Sybr green PCR master mix 
7.0 µl Rnase free water 
1.5 µl Primer forward 
1.5 µl Primer reverse 





















Appendix 4: Equipment 
Table 5 
Equipment for  making of NP  
Sonica Vibra cell VC750, 3mm tapered microtip Sonics & materials inc, USA  
Nalgene  centrifuge tube, 30 ml Nalgene, USA 
j-26 XP centrifuge Avanti®, BeckmanCoulter®, USA 
Labofuge 400R Heraus instruments, Germany 
Heto FD3 freezedrier Heto labequipment, Denmark 
 
Table 6 
Equipment for PLGA characterization   
Fluorescense analysis   
DM 6000 B Microscope Leica microsystems, Germany 
CTR 5 6000 Microscope Leica microsystems, Germany 
Object glass, 50 elka, 75x26 mm no 2400 Assistent® 
Apllication suite software Leica, Germany 
Measurement of PLGA particles   
Biocapby erlab vertical sterile bench Biocapby erlab, Germany 
Submicron particle sizer model 370-s Nicomp particle sizing systems, USA 
CW388 version 1.68 software Nicomp particle sizing systems, USA 
Surface characterization   
EM FC6 cryo unit Leica, Germany 
EM UC6 ultra microtom Leica, Germany 
JEOL JSM-6300 Scanning Electron microscope  JEOL Ltd, Japan 
 
Table 7 
Equipment for injection of PLGA  
1, 5 and 10 ml sterile syringe BD Plastipak® 
Microlance 25 G needles BD Plastipak® 




Equipment for isolation of fish 
macrophages/leukocytes  
Petri-dishes  
Pipette FINNPIPETTE, Finland 
Falcon cell strainer 100µm FALCON® 
96/24 wells BD Plastipak® 
Sterile stainless surgical blades 22, no 4 fitment Lance paragon Ltd, UK 
Scalpel no 4 Comac 
Scissors  
Tweezers Comac 
Vacutainer precisionglide Beckham Pickinson vacutainer systems 
Vacutainer glasses 4,5 ml Beckham Pickinson vacutainer systems 
Microlance needles 25 and 23 G BD plastipak® 










50 ml nunc vial  
Bürker chamber (counting-chamber), 0,100 mm 
depth, 0,0025 mm2 Assistant® 
 
Table 9 
Equipment for histology and sampling of organs  
20 ml plastic vials Zinsser analytic, Germany 
Scissors  
Scalpel no 4 Comac 
Sterile stainless surgical blades 22 no 4 fitment Lance Paragon Ltd, UK 
Tweezers Comac 
Vacutainer precisionglide Beckham Pickinson vacutainer systems 
Vacutainer glasses 4,5 ml Beckham Pickinson vacutainer systems 
Microlance needles 25 and 23 G BD plastipak® 
Dehydration machine Citadel 1000 Shandon, USA 
Leica EG 115 OH paraffin-oil machine Leica, Germany 
Immersion Oil Kebo Labs 
Cover glass, circular and rectangular Elka Assistant® 
Object-glass, 50 Elka, 75x26 mmr no 2400 Assistant® 
HI 1210 Water bath Leica, Germany 
RM2235 Cutter Leica, Germany 
Heating cupboard Termaks, Norway 
CP-4 cooling board Axel Johnson lab systems, Denmark 
 
Table 10 
Equipment for collection of IP-cells   
Specialized pipet tips for IP-Cells¹ FINNTIP® 
5 and 10 ml sterile syringe BD Plastipak® 
Microlance needles 27 G BD Plastipak® 
 
Table 11 
Equipment for visual analysis  
DM 6000 B Microscope Leica, Germany 
CTR 6000 microscope Leica, Germany 
Application suite software Leica, Germany 
Circular cover-glass Knittel glaser, Germany 
Rectangular cover-glass 24x24 mm rectangular Knittel glaser, Germany 
Object-glass, 50 Elka, 75x26 med mer no 2400 Assistant® 
 
Table 12 
Equipment for total RNA isolation   
Greiner tubes   
Ultra-turrax® T25 Basic IKA®, Werke, Norway 
Eppendorf    
Heating board Termaks, Norway 
Eppendorf Centrifuge 5417  Eppendorf BB lab AS, UK 
 
Table 13 
Equipment for Reverse transcriptase and Real-Time PCR  










7000 systems SDS software Applied Biosystems, USA 
Microamp™ optical 96-well reaction plate w/barcode Applied Biosystems, USA 
Microamp™ Optical Adhesive films Applied biosystems,USA 
Heating board Termaks, Norway 
Abgene 0.2 ml Thermo-strip, 8 tubes and caps Abgene, UK 




Equipment for RNA quality check   
Biorad power pack 300 Biorad, Norway 
Biokey Screener 8 gel chamber Biokeystone, US 
Genius Bio imaging systems Syngene, UK 
Genesnap software Syngene,  UK 
Nanodrop® ND-1000 spectrophotometer Nanodrop technologies, US 
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